It appears that you are currently using Ad Blocking software. What are the consequences? Click here to learn more.
Diabetes Developments - A blog on latest developments in diabetes by David Mendosa

The Gliptins are Coming

July 5th, 2006 · 2 Comments

The gliptins are coming to dinner. And to breakfast and lunch.

The gliptins are a promising new class of drugs that block the enzyme known by the catchy name dipeptidyl peptidase 4 or DPP-4. They include two drugs, vildagliptin (proposed trade name Galvus) from the Swiss pharamaceutical giant Novartis and sitagliptin phosphate (proposed trade name Januvia) from an American company, Merck. [Read more →]

Share

Tags: , ,
Posted in: Diabetes Medication

HONcode certification seal.